CoChat

Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Purpose The aim of this study was to identify characteristics of hypogammaglobulinemia secondary to glucocorticoid therapy and their value in the differential diagnosis to primary forms of antibody deficiency. Methods We investigated prevalence and character of hypogammaglobulinemia in a cohort of 36 patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) on glucocorticoid therapy in comparison to a gender- and age-matched cohort of hospital controls. We therefore determined serum immunoglobulin levels as well as B- and T cell-subsets in the peripheral blood of all participants. In addition, prior serum immunoglobulin levels and clinical data of the GCA and PMR patients were extracted from the electronic patient data-base. Results 21/36 GCA/PMR patients on glucocorticoid treatment developed antibody deficiency. In 19 patients this included IgG and in 13 patients IgG was the only affected isotype. The reduction of IgG was persistent in nearly 50 % of these patients during the observed period. GCA/PMR patients had reduced circulating naive and transitional B cells (p = 0.0043 and p = 0.0002 respectively) while IgM, IgG and IgA memory B cells were preserved. Amongst T-cell subsets, we found a reduction of CD4 memory T cells (p Conclusion Persistent humoral immunodeficiency occurs in about a quarter of GCA/PMR patients under glucocorticoid therapy. Because most patients have isolated IgG deficiency, preserved IgA production and class-switched memory B cells, by…

Overview

Integrity signals

Registry

Crossref · 10.1007/s10875-016-0264-7

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 21 references

Cited by

See all 64

Metadata

Authors
Wirsum, C., Glaser, C., Gutenberger, S., Keller, B., Unger, S., Voll, R. E., Vach, W., Ness, T., & Warnatz, K.
Affiliations
  • University of Freiburg (DE)
  • University Medical Center Freiburg (DE)
Corresponding author
Warnatz, Klaus
Venue
Journal of Clinical Immunology
Published
2016-03-15
Volume
36
Issue
4
Pages
406-412
ISSN
  • 0271-9142 (ISSN-L)
  • 1573-2592
OpenAlex
W2297268963
Cited by
64
References
21
Citations by year
2026: 1 · 2025: 7 · 2024: 12 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 10 · 2017: 4
FWCI
3.64
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Clinical Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
German Federal Ministry of Education and Research (BMBF 01EO1303)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
Keywords
secondary hypogammaglobulinemia, glucocorticoid therapy, primary antibody deficiency, giant cell arteritis, polymyalgia rheumatica, naive B cells, transitional B cells, memory B cells, regulatory T cells, memory CD4+ T cells, common variable immunodeficiency, differential diagnosis
MeSH terms
Agammaglobulinemia, Aged, Aged, 80 and over, Female, Glucocorticoids, Humans, Immunoglobulins, Male, Middle Aged, Polymyalgia Rheumatica, Prednisone, Giant Cell Arteritis, Prevalence, B-Lymphocyte Subsets, T-Lymphocyte Subsets

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency. https://app.cochat.ai/papers/10.1007/s10875-016-0264-7
The paper
Wirsum, C., Glaser, C., Gutenberger, S., Keller, B., Unger, S., Voll, R. E., Vach, W., Ness, T., & Warnatz, K. (2016). Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-016-0264-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.